drugset / Trial / NCT00758849
Fipamezole in Neurogenic Orthostatic Hypotension
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Fipamezole is effective in the treatment of orthostatic hypotension and related symptoms in multiple system atrophy and Parkinson's disease.
Timeline
- Start
- 2008-09
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fipamezole | Small molecule | 30 mg | — |
| Comparator | Fipamezole | Small molecule | 60 mg | — |
| Comparator | Fipamezole | Small molecule | 90 mg | — |